Prostate cancer
Conditions
Interventions
51.6GyRBE in 12 fractions with a fractional dose of 4.3GyRBE (4 times per week)
Sponsors
Narita Memorial Proton Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Histologically diagnosed primary prostate adenocarcinoma 2) Either clinical stage of T1-T3b and N0M0, in accordance with UICC (2017) 3) ECOG Performance status is 0, 1 or 2 4) Twenty years old of age at registration or more 5) Patient without active double cancer or severe basic disease 6) Patient who can keep his posture during irradiation 7) Technically being able to be irradiated 8) Written informed consent
Exclusion criteria
Exclusion criteria: 1) Patient without tissue specimen of biopsy 2) Patient with past history of radiotherapy for the targeted lesion 3) Patient with past history of surgery for the target lesion 4) Patient with active and intractable infection in the targeted lesion 5) Patient who is administrated more than two anticoagulant drugs 6) Inflammatory bowel diseases or after the surgery of rectal cancer 7) Patient who cannot be put the metal marker or spacer 8) Patient with severe disease 9) Judged as inappropriate to participation by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early-phase (< 90 days after start of irradiation) bladder/urinary adverse event rate (>Grade 2) | — |
Countries
Japan
Contacts
Public ContactTakeshi Yanagi
Narita memorial proton center Department of proton
Outcome results
None listed